Fitch Upgrades Bausch + Lomb, Bausch Health But Keeps Both Junk
Fitch Ratings upgraded its credit grade on both Bausch + Lomb Corp. and its parent company Bausch Health Cos., but…
10,700€
2,39%
Echtzeit-Aktienkurs Bausch + Lomb Corp.
Bid:
Ask:
Nachrichten zur Bausch + Lomb Corp. Aktie
This+time%E2%80%99s+not+different%3A+Don%E2%80%99t+let+negativity+bias+affect+investing+strategy
The year is 1910. Rochester’s local startup — Kodak — is growing rapidly. Bausch & Lomb and Gleason too.…
Stocks making the biggest moves midday: Rocket Lab, Lululemon, AppLovin, Bausch + Lomb and more
These are the stocks posting the largest moves in midday trading.…
Bausch + Lomb credit rating upgraded to ’B’ at S&P, parent company outlook developing By Investing.com
Bausch + Lomb credit rating upgraded to ’B’ at S&P, parent company outlook developing…
Bausch + Lomb: Solid 2024 Results, But Lets Address The Elephant In The Room
…
Bausch + Lomb (BLCO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Bausch + Lomb (BLCO) give a sense of how the business performed in…
Bausch + Lomb (BLCO) Surpasses Q4 Earnings and Revenue Estimates
Bausch + Lomb (BLCO) delivered earnings and revenue surprises of 4.17% and 1.17%, respectively, for the quarter ended December 2024.…
Unlocking Q4 Potential of Bausch + Lomb (BLCO): Exploring Wall Street Estimates for Key Metrics
Looking beyond Wall Streets top -and-bottom-line estimate forecasts for Bausch + Lomb (BLCO), delve into some of its key metrics…
InflammX Therapeutics Announces Option Agreement with Bausch + Lomb
TAMPA, Fla., Jan. 10, 2025 (GLOBE NEWSWIRE) -- InflammX Therapeutics Inc., a clinical-stage biotechnology company focused on developing…
BofA rates Bausch & Lomb ‘underperform’ with lower buyout chances By Investing.com
BofA rates Bausch & Lomb ‘underperform’ with lower buyout chances…
Bausch + Lomb down after report that Blackstone could back away from takeover bid By Investing.com
Bausch + Lomb down after report that Blackstone could back away from takeover bid…
Bausch + Lomb buyout teeters as Blackstone balks at price tag
Private equity group likely to drop out of consortium with TPG exploring bid for eyecare group…
Bausch + Lomb And Bausch Health: Some Incremental Progress As We Wait For Sale News
…
Banks, Private Credit Vie for $5 Billion Bausch + Lomb Debt
Banks and private credit firms are competing to provide at least $5 billion of debt financing to help fund a…
Private equity suitors line up for Bausch + Lomb eyecare auction
Sale process comes after tensions between investors and creditors over plan to split from Bausch Health…
Bausch Health Taps Jefferies to Refinance Debt, Aid Spinoff
Bausch Health Cos. is working with Jefferies Financial Group to explore refinancing some of its debt to aid a long-planned…
Op-ed: Here’s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors
Hedge fund managers sit on the boards of Bausch Health and Bausch + Lomb. They don’t think like your typical…
Bausch + Lomb (BLCO) Surges 14.5%: Is This an Indication of Further Gains?
Bausch + Lomb (BLCO) witnessed a jump in share price last session on above-average trading volume. The latest trend in…
Bausch + Lomb explores sale amid parent companys debt woes
Bausch + Lomb explores sale amid parent companys debt woes - report…
Bausch & Lomb reportedly exploring sale, shares rise
Bausch & Lomb stock surged on reports the American-Canadian eye health products firm is exploring a sale as it seeks…
Canadian Pharma Stocks: 5 Biggest Companies in 2024
The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription…
Earnings call: Bausch + Lomb sees robust growth, raises guidance By Investing.com
Earnings call: Bausch + Lomb sees robust growth, raises guidance…
Bausch + Lomb shares climb on earnings beat, raised outlook By Investing.com
Bausch + Lomb shares climb on earnings beat, raised outlook…
Surging Earnings Estimates Signal Upside for Bausch + Lomb (BLCO) Stock
Bausch + Lomb (BLCO) shares have started gaining and might continue moving higher in the near term, as indicated by…
Bausch + Lomb board welcomes new director Karen Ling By Investing.com
Bausch + Lomb board welcomes new director Karen Ling…